GSTT1 and GSTM1 polymorphisms predict treatment outcome for breast cancer: a systematic review and meta-analysis

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Tumor Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13277-015-4401-3PMID 26577857
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics, 2012

  2015cited by this paper
• Genetic variability of glutathione S-transferases influences treatment outcome of breast cancer

  2015cited by this paper
• Glutathione S-transferase gene GSTM1, gene-gene interaction, and gastric cancer susceptibility: evidence from an updated meta-analysis

  2014cited by this paper
• Predictive potential role of glutathione S-transferases polymorphisms on prognosis of breast cancer.

  2014cited by this paper
• GSTT1 and GSTM1 polymorphisms predict treatment outcome for acute myeloid leukemia: a systematic review and meta-analysis

  2014cited by this paper
• The association between the GSTP1 A313G and GSTM1 null/present polymorphisms and the treatment response of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients: a meta-analysis

  2014cited by this paper
• Interactive effect of glutathione S-transferase M1 and T1 polymorphisms on hepatocellular carcinoma

  2014cited by this paper
• The Associations between Two Vital GSTs Genetic Polymorphisms and Lung Cancer Risk in the Chinese Population: Evidence from 71 Studies

  2014cited by this paper
• Glutathione S-transferase gene polymorphisms and susceptibility to acute myeloid leukemia: meta-analyses.

  2014cited by this paper
•  GSTT1, GSTM1, and GSTP1 polymorphisms as a prognostic factor in women with breast cancer.

  2014cited by this paper
• Pharmacogenetic Influence of GST Polymorphisms on Anthracycline-Based Chemotherapy Responses and Toxicity in Breast Cancer Patients: A Multi-Analytical Approach

  2013cited by this paper
• The Association of Glutathione S-transferase Gene Mutations (including GSTT1 and GSTM1) with the Prognostic Factors and Relapse in Acute Lymphoblastic Leukemia

  2013cited by this paper
• Associations between null mutations in GSTT1 and GSTM1, the GSTP1 Ile105Val polymorphism, and mortality in breast cancer survivors

  2013cited by this paper
• Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review

  2012cited by this paper
• Polymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patients

  2012cited by this paper
• Predictive role of GSTs on the prognosis of breast cancer patients with neoadjuvant chemotherapy.

  2012cited by this paper
• Clinical response to chemotherapy in locally advanced breast cancer was not associated with several polymorphisms in detoxification enzymes and DNA repair genes.

  2012cited by this paper
• Genetic variants in oxidative stress-related genes predict chemoresistance in primary breast cancer: a prospective observational study and validation.

  2012cited by this paper
• Glutathione S-transferase M1 and T1 polymorphism and response to neoadjuvant chemotherapy (CAF) in breast cancer patients

  2011cited by this paper
• Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Association of GSTs gene polymorphism with response to chemotherapy in breast cancer

  2010cited by this paper
• Frequency distribution of GSTM1 and GSTT1 null allele in Pakistani population and risk of disease incidence.

  2010cited by this paper
• GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer.

  2010cited by this paper
• Cyclophosphamide- metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study

  2010cited by this paper
• Glutathione-S-Transferase-Pi Expression in Early Breast Cancer: Association With Outcome and Response to Chemotherapy

  2010cited by this paper
• [Establishment of a multiplex ligation-dependent SNP genotyping method and its application in the detection of genes related to chemotherapeutic drugs in breast cancer].

  2009cited by this paper
• Correlation of polymorphism C3435T of the MDR-1 gene and the response of primary chemotherapy in women with locally advanced breast cancer.

  2008cited by this paper
• Multiple Genetic Polymorphisms of GSTP1 313AG, MDR1 3435CC, and MTHFR 677CC Highly Correlated with Early Relapse of Breast Cancer Patients in Taiwan

  2008cited by this paper
• The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia.

  2007cited by this paper
• Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival

  2007cited by this paper
• Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancer.

  2005cited by this paper
• Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.

  2005cited by this paper
• Genetic polymorphisms in glutathione‐S‐transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma

  2005cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• The role of glutathione-S-transferase in anti-cancer drug resistance

  2003cited by this paper
• Glutathione S-transferases (GSTT1 and GSTM1) gene deletions in Tunisians: susceptibility and prognostic implications in breast carcinoma

  2003cited by this paper
• Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy

  2002cited by this paper
• Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer.

  2001cited by this paper
• Glutathione-S-transferase family of enzymes.

  2001cited by this paper
• Glutathione S-Transferase Mu Modulates the Stress-activated Signals by Suppressing Apoptosis Signal-regulating Kinase 1*

  2001cited by this paper
• Methods for Meta-Analysis in Medical Research

  2000cited by this paper
• Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress.

  1999cited by this paper
• Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancer

  1999cited by this paper
• Bias in meta›analysis detected by a simple, graphical test

  1998cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Operating characteristics of a rank correlation test for publication bias.

  1994cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper

• Identification of Goat Supernumerary Teat Phenotype Using Wide-Genomic Copy Number Variants

  2024cites this paper
• Potential role of genetic polymorphisms in neoadjuvant chemotherapy response in breast cancer

  2024influential citation
• BPDE-DNA adduct formation and alterations of mRNA, protein, and DNA methylation of CYP1A1, GSTP1, and GSTM1 induced by benzo[a]pyrene and the intervention of aspirin in mice

  2023cites this paper
• Pharmacogenomic Profile of Amazonian Amerindians

  2022cites this paper
• Association Between the XRCC1, GSTM1, and GSTT1 Polymorphisms in Model of Thyroid Cancer: A Meta-Analysis

  2022cites this paper
• A Risk Score System Based on the Methylation Levels of 15 RNAs in Breast Cancer

  2021cites this paper
• Evaluation of molecular markers GSTM1 and GSTT1 and clinical factors in breast cancer: case-control study and literature review

  2021cites this paper
• Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia

  2021cites this paper
• GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel‐Based Chemotherapy in Ovarian Cancer

  2020cites this paper
• Prognosis of hormone-dependent breast cancer seems to be influenced by KEAP1, NRF2 and GSTM1 genetic polymorphisms

  2019cites this paper
• GSTs and chronic myeloid leukemia Age-and gender-independent association of glutathione S-transferase null polymorphisms with chronic myeloid leukemia

  2019cites this paper
• Age- and gender-independent association of glutathione S-transferase null polymorphisms with chronic myeloid leukemia.

  2019cites this paper
• Transcriptome signatures of p,p´-DDE-induced liver damage in Mus spretus mice.

  2018cites this paper
• Recent advances in protein engineering and biotechnological applications of glutathione transferases

  2018cites this paper
• Genetic variants and increased risk of meningioma: an updated meta-analysis

  2017cites this paper
• Glutathione S-transferase M1 polymorphism and the risk of pancreatitis

  2017cites this paper
• Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy

  2017cites this paper
• Note of the methodological flaws in the paper entitled “GSTT1 and GSTM1 polymorphisms predict treatment outcome for breast cancer: a systematic review and meta-analysis”

  2016cites this paper